相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 技术资料
- 保存条件:
Powder: 2-8℃,2 years
- 保质期:
Powder: 2-8℃,2 years
- 英文名:
CEP-28122 mesylate salt
- 库存:
现询
- 供应商:
北京索莱宝科技有限公司
- CAS号:
1022958-60-6(free base)
- 规格:
5mg
CAS:1022958-60-6(free base)
| 基本信息 | |
| CAS | No.1022958-60-6(free base) |
| 英文名称 | CEP-28122 mesylate salt |
| 分子式 | C29H39ClN6O6S |
| 分子量 | 635.17 |
| 溶解性 | Soluble in DMSO ≥0.1mg/mL(Need ultrasonic) |
| 纯度 | ≥98% |
| 外观(性状) | Solid |
| 储存条件 | Powder: 2-8℃,2 years |
| SMILES | COC1=C(C=CC2=C1CCC(CC2)N3CCOCC3)NC4=NC=C(C(=N4)NC5C6CC(C5C(=O)N)C=C6)Cl.CS(=O)(=O)O |
| InChIKey | PIIIZYXUYVVFSN-WWQCAQLDSA-N |
| InChI | InChI=1S/C28H35ClN6O3.CH4O3S/c1-37-25-20-8-7-19(35-10-12-38-13-11-35)6-4-16(20)5-9-22(25)32-28-31-15-21(29)27(34-28)33-24-18-3-2-17(14-18)23(24)26(30)36;1-5(2,3)4/h2-3,5,9,15,17-19,23-24H,4,6-8,10-14H2,1H3,(H2,30,36)(H2,31,32,33,34);1H3,(H,2,3,4)/t17-,18+,19+,23+,24-;/m1./s1 |
| PubChem CID | 91885507 |
| 靶点 | ALK |
| 通路 | Protein Tyrosine Kinase/RTK;Angiogenesis |
| 背景说明 | CEP-28122 mesylate salt 是一种高度有效的选择性的 ALK 抑制剂。 |
| 生物活性 | CEP-28122 mesylate salt, a diaminopyrimidine derivative, is a potent, selective, and orally bioavailable ALK inhibitor, with an IC50 value of 1.9 nM for recombinant ALK kinase activity. CEP-28122 has antitumor activity in experimental models of ALK-positive human cancers. CEP-28122 mesylate salt has good pharmacodynamic and pharmacokinetic activity[1]. |
| In Vitro | CEP-28122 mesylate salt(3-3000 nM; 48 hours)treatment leads to concentration-dependent growth inhibition of Karpas-299 and Sup-M2 cells in culture,associates with concentration-related caspase 3/7 activation.CEP-28122 mesylate salt(30-1000 nM; 2 hours)treatment leads to substantial suppression of phosphorylation of putative downstream effectors of ALK in Sup-M2 cells,indicating that the downstream signaling pathways are mediated by individual ALK fusion protein[1]. |
| 细胞实验 | CEP-28122 mesylate salt(3-30 mg/kg; oral gavage; twice a day; 12 days)produces dose-dependent antitumor activity in Sup-M2 subcutaneous tumor xenografts in SCID mice.In contrast,CEP-28122 has no antitumor activity in nu/nu mice bearing HCT116,suggesting that the antitumor activity of CEP-28122 in NPM-ALK–positive Sup-M2 tumor models is due to sustained NPM-ALK inhibition in tumors [1]. |
| 数据来源文献 | [1]. Mangeng Cheng, et al. CEP-28122, a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancers. Mol Cancer Ther. 2012 Mar;11(3):670-9. |
| 单位 | 瓶 |
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
技术资料暂无技术资料 索取技术资料
IC6070 CEP-28122 mesylate salt 蛋白酪氨酸激酶 索莱宝
¥2200









